Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Use of a National Electronic Health Record Network to Describe Characteristics and Healing Patterns of Sickle Cell Ulcers.

Flattau A, Gordon H, Vinces G, Ennis WJ, Minniti CP.

Adv Wound Care (New Rochelle). 2018 Aug 1;7(8):276-282. doi: 10.1089/wound.2018.0788.

2.

l-Glutamine and the Dawn of Combination Therapy for Sickle Cell Disease.

Minniti CP.

N Engl J Med. 2018 Jul 19;379(3):292-294. doi: 10.1056/NEJMe1800976. No abstract available.

PMID:
30021091
3.

Nutritional supplement profile of adults with sickle cell disease.

Crouch EM, Bonham VL, Abdallah K, Buscetta A, Vinces G, Heo M, Minniti CP.

Am J Hematol. 2018 May 4. doi: 10.1002/ajh.25129. [Epub ahead of print] No abstract available.

PMID:
29726579
4.

HO-1hi patrolling monocytes protect against vaso-occlusion in sickle cell disease.

Liu Y, Jing F, Yi W, Mendelson A, Shi P, Walsh R, Friedman DF, Minniti C, Manwani D, Chou ST, Yazdanbakhsh K.

Blood. 2018 Apr 5;131(14):1600-1610. doi: 10.1182/blood-2017-12-819870. Epub 2018 Feb 2.

PMID:
29437594
5.

Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.

Boulad F, Shore T, van Besien K, Minniti C, Barbu-Stevanovic M, Fedus SW, Perna F, Greenberg J, Guarneri D, Nandi V, Mauguen A, Yazdanbakhsh K, Sadelain M, Shi PA.

Haematologica. 2018 May;103(5):770-777. doi: 10.3324/haematol.2017.187047. Epub 2018 Feb 1.

6.

Comprehensive management reduces incidence and mortality of acute chest syndrome in patients with sickle cell disease.

Basishvili G, Gotesman J, Vandervoort K, Jacobs C, Vattappally L, Minniti CP.

Am J Hematol. 2018 Mar;93(3):E64-E67. doi: 10.1002/ajh.24994. Epub 2018 Jan 12. No abstract available.

PMID:
29205462
7.

The psychosocial impact of leg ulcers in patients with sickle cell disease: I don't want them to know my little secret.

Umeh NI, Ajegba B, Buscetta AJ, Abdallah KE, Minniti CP, Bonham VL.

PLoS One. 2017 Oct 18;12(10):e0186270. doi: 10.1371/journal.pone.0186270. eCollection 2017.

8.

Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease.

Sachdev V, Sidenko S, Wu MD, Minniti CP, Hannoush H, Brenneman CL, Waclawiw MA, Arai AE, Schechter AN, Kato GJ, Lindner JR.

Br J Haematol. 2017 Nov;179(4):648-656. doi: 10.1111/bjh.14918. Epub 2017 Sep 7.

PMID:
28880374
9.

Sickle Cell Anemia and Comorbid Leg Ulcer Treated With Curative Peripheral Blood Stem Cell Transplantation.

Connor JL Jr, Minniti CP, Tisdale JF, Hsieh MM.

Int J Low Extrem Wounds. 2017 Mar;16(1):56-59. doi: 10.1177/1534734616685636. Epub 2017 Jan 9.

PMID:
28682672
10.

Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease.

Janakiram M, Verma A, Wang Y, Budhathoki A, Suarez Londono J, Murakhovskaya I, Braunschweig I, Minniti CP.

Leuk Lymphoma. 2018 Jan;59(1):241-244. doi: 10.1080/10428194.2017.1324158. Epub 2017 Jun 7. No abstract available.

PMID:
28587497
11.

Lifespan care in SCD: Whom to transition, the patients or the health care system?

Minniti CP, Vichinsky E.

Am J Hematol. 2017 Jun;92(6):487-489. doi: 10.1002/ajh.24685. Epub 2017 Apr 6. No abstract available.

12.

Prostacyclin-analog therapy in sickle cell pulmonary hypertension.

Weir NA, Saiyed R, Alam S, Conrey A, Desai HD, George MP, Keeley JH, Klings ES, Mehari A, Taylor JG 6th, Minniti CP, Kato GJ.

Haematologica. 2017 May;102(5):e163-e165. doi: 10.3324/haematol.2015.131227. Epub 2017 Jan 25. No abstract available.

13.

Severe cardiac iron toxicity in two adults with sickle cell disease.

Oduor H, Minniti CP, Brofferio A, Gharib AM, Abd-Elmoniem KZ, Hsieh MM, Tisdale JF, Fitzhugh CD.

Transfusion. 2017 Mar;57(3):700-704. doi: 10.1111/trf.13961. Epub 2016 Dec 26.

14.

Estimación de actividades preventivas en pacientes con enfermedad pulmonar obstructiva crónica. Estudio ADEPOCLE.

De Abajo Larriba AB, Díaz Rodríguez Á, González-Gallego J, Peleteiro Cobo B, Capón Álvarez J, Mahmoud Atoui O, Méndez Rodríguez E, De Abajo Olea S, Lumbreras González V, Minniti C.

Nutr Hosp. 2016 Sep 20;33(5):585. doi: 10.20960/nh.585. Spanish.

15.

Autologous stem cell-based therapy for sickle cell leg ulcer: a pilot study.

Meneses JV, Fortuna V, de Souza ES, Daltro GC, Meyer R, Minniti CP, Borojevic R.

Br J Haematol. 2016 Dec;175(5):949-955. doi: 10.1111/bjh.14326. Epub 2016 Sep 8.

PMID:
27604498
16.

Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report.

Zheng CY, Minniti CP, Chaitowitz MH.

Hemoglobin. 2016 Jun;40(3):220-2. doi: 10.3109/03630269.2016.1149077. Epub 2016 Mar 9.

PMID:
26956672
17.

Osteonecrosis of the Hip in Hematologic Disease: A Review of Conditions and Treatment Options.

Sorich MM, Cherian JJ, McElroy MJ, Banerjee S, Jones LC, Minniti CP, Mont MA.

J Long Term Eff Med Implants. 2015;25(4):253-68. Review.

PMID:
26852634
18.

Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease.

Nguyen KL, Tian X, Alam S, Mehari A, Leung SW, Seamon C, Allen D, Minniti CP, Sachdev V, Arai AE, Kato GJ.

Haematologica. 2016 Feb;101(2):e40-3. doi: 10.3324/haematol.2015.125229. Epub 2015 Nov 20. No abstract available.

19.

Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia.

Fitzhugh CD, Hsieh MM, Allen D, Coles WA, Seamon C, Ring M, Zhao X, Minniti CP, Rodgers GP, Schechter AN, Tisdale JF, Taylor JG 6th.

PLoS One. 2015 Nov 17;10(11):e0141706. doi: 10.1371/journal.pone.0141706. eCollection 2015.

20.

A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease.

Altman IA, Kleinfelder RE, Quigley JG, Ennis WJ, Minniti CP.

Int Wound J. 2016 Dec;13(6):1315-1324. doi: 10.1111/iwj.12522. Epub 2015 Nov 4. Review.

PMID:
26537664

Supplemental Content

Loading ...
Support Center